Recent findings suggest that the mTOR signaling pathway may be involved in the vascular lesions associated with antiphospholipid syndrome, as aPLs bind to renal vascular endothelial cells and activate the mTOR complex [12,13]. This evidence concerns the gene MTOR and antiphospholipid syndrome.